日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Escherichia coli O8 Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP485178EOO
CSB-EP485178EOO
CSB-BP485178EOO
CSB-MP485178EOO
CSB-EP485178EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP485179EOO
CSB-EP485179EOO
CSB-BP485179EOO
CSB-MP485179EOO
CSB-EP485179EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 HTH-type transcriptional regulator iscR (iscR) CSB-YP485180EOO
CSB-EP485180EOO
CSB-BP485180EOO
CSB-MP485180EOO
CSB-EP485180EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Homoserine O-succinyltransferase (metA) CSB-YP485181EOO
CSB-EP485181EOO
CSB-BP485181EOO
CSB-MP485181EOO
CSB-EP485181EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Maltoporin (lamB) CSB-YP485182EOO
CSB-EP485182EOO
CSB-BP485182EOO
CSB-MP485182EOO
CSB-EP485182EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Cytochrome c-552 (nrfA) CSB-YP485183EOO
CSB-EP485183EOO
CSB-BP485183EOO
CSB-MP485183EOO
CSB-EP485183EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP485184EOO
CSB-EP485184EOO
CSB-BP485184EOO
CSB-MP485184EOO
CSB-EP485184EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase (fabA) CSB-YP485185EOO
CSB-EP485185EOO
CSB-BP485185EOO
CSB-MP485185EOO
CSB-EP485185EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP485186EOO
CSB-EP485186EOO
CSB-BP485186EOO
CSB-MP485186EOO
CSB-EP485186EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 tRNA1 (Val) (adenine (37)-N6)-methyltransferase CSB-YP485187EOO
CSB-EP485187EOO
CSB-BP485187EOO
CSB-MP485187EOO
CSB-EP485187EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 DNA mismatch repair protein mutL (mutL) CSB-YP485188EOO
CSB-EP485188EOO
CSB-BP485188EOO
CSB-MP485188EOO
CSB-EP485188EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Probable L-ascorbate-6-phosphate lactonase ulaG (ulaG) CSB-YP485189EOO
CSB-EP485189EOO
CSB-BP485189EOO
CSB-MP485189EOO
CSB-EP485189EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Putative aminoacrylate peracid reductase RutC (rutC) CSB-YP485190EOO
CSB-EP485190EOO
CSB-BP485190EOO
CSB-MP485190EOO
CSB-EP485190EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Glucans biosynthesis protein G (mdoG) CSB-YP485191EOO
CSB-EP485191EOO
CSB-BP485191EOO
CSB-MP485191EOO
CSB-EP485191EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Multidrug resistance protein MdtH (mdtH), partial CSB-YP485192EOO
CSB-EP485192EOO
CSB-BP485192EOO
CSB-MP485192EOO
CSB-EP485192EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Protein grpE (grpE) CSB-YP485193EOO
CSB-EP485193EOO
CSB-BP485193EOO
CSB-MP485193EOO
CSB-EP485193EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Protein RecA (recA) CSB-YP485194EOO
CSB-EP485194EOO
CSB-BP485194EOO
CSB-MP485194EOO
CSB-EP485194EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 30S ribosomal protein S18 (rpsR) CSB-YP485195EOO
CSB-EP485195EOO
CSB-BP485195EOO
CSB-MP485195EOO
CSB-EP485195EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0412 protein yaaI (yaaI) CSB-YP485196EOK
CSB-EP485196EOK
CSB-BP485196EOK
CSB-MP485196EOK
CSB-EP485196EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Acid shock protein (asr) CSB-YP485197EOK
CSB-EP485197EOK
CSB-BP485197EOK
CSB-MP485197EOK
CSB-EP485197EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×